Latest News | Advent Buys Controlling Stake in Deal Valuing Avra Labs at USD 100 Mln

Mumbai, Jan 24 (PTI) Global private equity fund Advent International on Monday said it will be acquiring a controlling stake in pharma sector-focused Avra Laboratories, in a deal which values the company promoted by A V Rama Rao at USD 100 million.

The 26-year-old Avra is headquartered in Hyderabad and engaged in contract manufacturing and research services and speciality active pharmaceutical ingredients. A definitive agreement has been signed between both the parties for the deal, as per a statement.

Also Read | Realme 9 Pro Price in India & Specifications Leaked Online: Report.

The statement did not disclose details on valuations, but officials privy to the matter pegged the valuation of the company started by Padmabhushan awardee Rao and his family at USD 100 million.

Avra has four facilities across Telangana and Andhra Pradesh, and is focused on niche generic molecules and also proprietary custom synthesis business for global pharmaceutical players.

Also Read | Google Cloud To Open New Office in Pune Later This Year.

Rao, the founder and managing director of the company, said he is confident of Avra will see sustained growth and reach newer markets.

Advent International India's managing director Pankaj Patwari said the private equity fund wants to create top five merchant API Platform in India and the deal will also allow it to be present across the spectrum of generic and patented molecules.

The PE fund, which has been investing in India since 2007, and its bets in the last one year include ZCL Chemicals, Eureka Forbes, Classy Kontainers and Encora.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)